Soluble ST2: A Novel Prognostic Biomarker of Heart Failure

Rector, T. S., & Anand, I. S. (2010). Research Needed to Support Clinical Use of Biomarkers as Prognostic Indicators for Patients with Heart Failure. Cardiology Research and Practice, 2010(), 97-102. https://doi.org/10.4061/2010/453851
吳宇暉、李慶孝、阮祺文、蕭慧甄、張萱稜、陳怡秀（2010）。New Biomarker for Heart Failure Diagnosis: BNP and Heart Failure Correlation Study。Journal of Biomedical & Laboratory Sciences，22(4)，128-133。https://doi.org/10.30046/JBLS.201012.0002
徐雅玫（2023）。SGLT2 inhibitors : A New Era in the Treatment of Heart Failure。彰化護理，30(1)，20-25。https://doi.org/10.6647/CN.202303_30(1).0005
Vassiliadis, E., Barascuk, N., Didangelos, A., & Karsdal, M. A. (2012). Novel Cardiac-Specific Biomarkers and the Cardiovascular Continuum. Biomarker Insights, 2012(), 45-57. https://doi.org/10.4137/BMI.S9536
Ferreira, J. P., Santos, M., Almeida, S., Marques, I., Bettencourt, P., & Carvalho, H. (2014). High-Sensitivity Troponin T: A Biomarker for Diuretic Response in Decompensated Heart Failure Patients. Cardiology Research and Practice, (2014), h1-9. https://doi.org/10.1155/2014/269604